Ballerup, Denmark

Bent Højgaard

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Conaris Research Institute. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Bent Højgaard. Retrieved from https://idiyas.com/inventor/bent-højgaard-4l2r3snn

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Bent Højgaard

Introduction

Bent Højgaard is a notable inventor based in Ballerup, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly with his work on extended release formulations. His innovative approach has led to the development of a unique patent that enhances the delivery of nicotinamide.

Latest Patents

Højgaard holds a patent for an "Extended release nicotinamide formulation." This invention provides various extended release granules of nicotinamide, which can be further enhanced by the inclusion of a conductive filler. This advancement has the potential to improve the efficacy of nicotinamide in therapeutic applications.

Career Highlights

Bent Højgaard is associated with Conaris Research Institute AG, where he continues to explore new avenues in pharmaceutical research. His work has been instrumental in advancing the understanding of drug delivery systems and their applications in medicine.

Collaborations

Højgaard collaborates with Jørgen Wittendorff, a fellow researcher, to further enhance their innovative projects. Their combined expertise contributes to the development of cutting-edge solutions in the pharmaceutical industry.

Conclusion

Bent Højgaard's contributions to the field of pharmaceuticals through his innovative patent and collaborative efforts highlight his role as a significant inventor. His work continues to influence the development of effective drug delivery systems.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…